Churg–Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients. (19th May 2014)

• Record Type: Journal Article
• Authors: Yılmaz, İnsu; Çelik, Gülfem; Aydın, Ömür; Özdemir, Seçil Kepil; Soyyiğit, Şadan; Sözener, Zeynep; Özgüçlü, Selcan; Atasoy, Çetin; Düzgün, Nurşen; Mungan, Dilşad; Sin, Betül; Demirel, Yavuz Selim; Mısırlıgil, Zeynep
• Is Part Of: Clinical respiratory journal. Volume 9:Number 3(2015)
• Page Start: 350
• Page End: 358
• Publication Date: 2014-05-19
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 616.24
• DOI: 10.1111/crj.12154
• Languages: English
• ISSNs: 1752-6981

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="crj12154-sec-0001" sec-type="section"> <title>Introduction</title> <p>Churg–Strauss syndrome (CSS) is a rare multisystem vasculitis. Considering the variation of autoimmune diseases in different races, it is of interest to determine whether any outstanding features exist for Turkish patients with CSS.</p> </sec> <sec id="crj12154-sec-0002" sec-type="section"> <title>Objective</title> <p>The aim of this study was to evaluate the clinical and serological features of the disease, the treatment, and long‐term follow‐up details, and to investigate possible etiological factors of Turkish CSS patients.</p> </sec> <sec id="crj12154-sec-0003" sec-type="section"> <title>Methods</title> <p>The study included 14 patients who were diagnosed with CSS, and followed by our department between 2004 and 2012. Possible etiological factors, initial symptoms, clinical presentations, treatment, as well as outcomes were documented. The study was approved by the local ethics.</p> </sec> <sec id="crj12154-sec-0004" sec-type="section"> <title>Results</title> <p>All patients fulfilled the American College of Rheumatology criteria. Initial symptoms were worsening asthma (<italic>n</italic> = 14; 100%) and skin lesions (<italic>n</italic> = 6; 43%). All patients had a diagnosis of asthma and nasal polyps, whereas 57.1% had aspirin hypersensitivity at the time of diagnosis. The lungs (100%) and skin (43%) were most commonly involved. Peripheral eosinophilia dominated on initial presentations of all patients. Initial treatments included oral methyl prednisolone in all cases, whereas cyclophosphamide and azathioprine were used in three cases. Relapses were detected in five cases. None of the cases were able to stop the oral corticosteroid treatment. No fatalities were observed.</p> </sec> <sec id="crj12154-sec-0005" sec-type="section"> <title>Conclusion</title> <p>We herein describe a new severe asthma endotype in connection with CSS. We suggest that physicians who deal with uncontrolled severe asthma cases should consider CSS in the presence of nasal polyps, aspirin hypersensitivity, and especially peripheral blood eosinophilia over 10%.</p> </sec> </abstract>